Form CORRESP - Correspondence:
SEC Accession No. 0001193125-16-537182
Filing Date
2016-04-11
Accepted
2016-04-11 16:31:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 10410
  Complete submission text file 0001193125-16-537182.txt   11334
Mailing Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139
Business Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2835 In Vitro & In Vivo Diagnostic Substances